New Developments in Lymphoma Summer 2015 Newsletter
Message from John Leonard, MD Program Director
“To date 2015 has been a very exciting and productive year for the Lymphoma Program at Weill Cornell Medical College and NewYork-Presbyterian Hospital.”
Lymphoma Program Highlights
While we continue to believe that the future of oncology lies in targeted, non-chemotherapy drugs. A healthy lifestyle and outlook is also very important. In this issue of Lymphoma Program Highlights we are pleased to include articles written by experts in psycho-social care and nutrition detailing how attention paid to these areas can positively affect outcomes.
Clinical Trial Spotlight
This is a select list of our open trials. Currently there are over 30 open trials for various lymphomas at WCMC. A complete listing of our offerings can be found at: http://cornellmedicine.com/trials/
The purpose of this study is to obtain feedback from patients with indolent lymphoma on a new measure of patients’ understanding of their illness and treatment options and treatment preferences. We will use this feedback to improve the measure to be used in future studies.
- Age 21 years or older.
- Diagnosis of an indolent lymphoma including follicular lymphoma, marginal zone lymphoma, and chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Detailed eligibility reviewed when you contact the study team.
“At Weill Cornell Medical College we have the privilege of helping thousands of people every year. Every patient has an experience and we would like to highlight some of their advice here. For this issue Robert Azopardi answered some questions about changes in his lifestyle after his diagnosis with CLL.”